查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
智慧醫療設備市場：2023年至2028年預測
市場調查報告書
商品編碼
1410189

智慧醫療設備市場：2023年至2028年預測

Smart Medical Device Market - Forecasts from 2023 to 2028
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球智慧醫療設備市場預計將從2021年的1,363.95億美元增至2028年的2,713.43億美元，複合年成長率為10.33%。

全球智慧醫療設備市場的成長是由對無線和智慧型手機醫療設備的需求不斷成長、設備技術的突破以及消費者健身意識的提高所推動的。此外，對感測器、心電圖設備和帶有健身追蹤器的智慧型手錶等穿戴式醫療設備的需求正在增加，因為這些設備易於使用，不需要太多專業知識即可了解結果。因此，使用者可以監測自己的生命徵象並了解自己的健康狀況，而無需經常去診所或醫院。此外，預計老年人口將更容易採用這方面的智慧醫療設備。

此外，根據聯合國2022年7月發布的《2022年世界人口展望》更新資料，歐洲及北美地區2022年人口老化程度最高，約佔65歲及以上人口的19%。

慢性病增加

糖尿病、心血管疾病和呼吸系統疾病等慢性疾病的增加正在對全球智慧醫療設備市場產生重大影響。例如，根據 IDF 糖尿病地圖集（2021 年），10.5% 的成年人（20-79 歲）患有糖尿病，而根據同一資訊來源，到2045 年，將有7 億人（即八分之一的成年人）患有糖尿病近8300萬人將患有糖尿病，增加了46%。醫療保健產業對治療慢性病、為老年人提供高效的居家養老支持以及確保從住院護理到門診居家醫療的無縫過渡有著濃厚的興趣。智慧醫療設備透過正確遵循治療計劃和識別健康指標來幫助監控和管理解決方案。

印度智慧醫療設備市場預計將穩定成長。

在印度，智慧醫療設備產業近年來成長顯著，已成為整個醫療保健產業的重要組成部分。醫療保健成本上升以及印度政府努力促進醫療保健技術的使用等因素正在推動對智慧醫療設備的需求，從而導致對更容易獲得和更有效率的專業醫療技術的需求不斷增加。根據《2022-23 年經濟調查》，印度醫療保健公共支出佔 GDP 的 2.1%，而 2021 會計年度為 1.6%，2023 會計年度為 2.1%，2022 會計年度為 2.2%。

印度政府加大力度

印度政府的努力也在新興市場的成長和開拓中發揮重要作用。印度製造舉措不僅增強了印度的製造能力，也為強大的本土數位基礎設施鋪平了道路，為印度人民帶來了巨大利益。總理莫迪 (Narendra Modi) 在 2020 年第 84 個印度獨立日宣布了國家數位健康使命 (NDHM)，旨在建立一個生態系統，在印度各地提供更好的醫療保健服務。

這種現有的數位基礎設施可以有效地識別和連接個人，並透過數位手段簡化他們的日常生活，包括Aadhaar唯一身分（UID）、JAM三位一體（Jan Dhan-Aadhaar-Mobile）、統一支付介面（UPI ）等重要組件。這強大的數位基礎為 NDHM 提供了堅實的起點，促進數位管理醫療服務的進一步發展和增強。

市場主要發展

  • 2022年11月，美敦力在美國推出「美敦力擴展融合套裝」。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表

第2章調查方法

  • 調查資料
  • 先決條件

第3章執行摘要

  • 研究亮點

第4章市場動態

  • 市場促進因素
  • 市場抑制因素
  • 波特五力分析
  • 產業價值鏈分析

第5章全球智慧醫療設備市場：按類型

  • 介紹
  • 診斷和監測設備
  • 治療設備

第6章全球智慧醫療設備市場：依應用分類

  • 介紹
  • 心血管
  • 神經病學
  • 呼吸系統
  • 其他

第7章全球智慧醫療設備市場：依最終用戶分類

  • 介紹
  • 醫院和診所
  • 門診治療中心
  • 家庭護理設置

第8章全球智慧醫療設備市場：按地區

  • 介紹
  • 北美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 南美洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 歐洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 中東/非洲
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區
  • 亞太地區
    • 按類型
    • 按用途
    • 按最終用戶
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議與合作
  • 供應商競爭力指數

第10章 公司簡介

  • Boston Scientific Corporation
  • ViVO Smart Medical Devices Ltd
  • Dexcom Inc
  • Abbott Laboratories
  • Medtronic Plc.
  • NeuroMetrix, Inc.
  • Omron Healthcare, Inc.
簡介目錄
Product Code: KSI061611834

The global smart medical devices market is estimated to grow at a CAGR of 10.33% reaching US$271.343 billion in 2028 from US$136.395 billion in 2021.

The global smart medical devices market growth is being propelled by the increasing demand for wireless and smartphone-compatible medical equipment, device technology breakthroughs, and increased consumer awareness of fitness. Moreover, as these devices are simple to use and don't require a lot of specialized knowledge to understand the results, demand for wearable medical devices has increased like sensors, ECG devices, and smartwatches with fitness trackers. As a result, the user can monitor their vital signs to maintain tabs on their health status without having to often visit clinics or hospitals. Additionally, the elderly population is anticipated to adopt this aspect of smart medical devices more readily.

Furthermore, according to data updated by the UN in its World Population Prospectus 2022, which was published in July 2022, Europe and Northern America had the oldest populations in 2022, with nearly 19% of the population being 65 years of age or older.

Rising prevalence of chronic diseases

The rise in the prevalence of chronic diseases including diabetes, cardiovascular, and respiratory problems has a big impact on the global smart medical devices market. For instance, 10.5% of adults (20-79 years) have diabetes, according to the IDF Diabetes Atlas (2021), and as per the same source nearly 783 million adults, or one in eight, would have diabetes by 2045, a 46% rise. The healthcare sector is highly concerned with treating chronic illnesses, offering efficient aging-in-place support to an older population, and guaranteeing a seamless transition from inpatient hospital care to outpatient home care. By properly following the treatment plans and recognizing health metrics, smart medical devices assist in monitoring and managing solutions.

It is projected that the smart medical devices market in India will grow steadily.

India has been experiencing significant growth in the smart medical devices industry in recent years, making it a significant segment within the broader healthcare industry. Factors such as increasing healthcare expenditure followed by the Indian governmental initiatives to promote the use of technology in healthcare are driving the demand for smart medical devices, which in turn drives the need for specialized medical technologies making them more accessible and efficient. According to the Economic Survey 2022-23, India's public expenditure on healthcare touched 2.1 % of GDP in FY23 and 2.2% in FY22, against 1.6% in FY21.

Increasing Government Initiatives in India

Indian government initiatives are also playing a significant role in the growth and development of the smart medical devices market in the country. The Make in India initiative has not only bolstered the country's manufacturing capabilities but has also paved the way for a robust and domestically developed digital infrastructure, greatly benefiting the citizens. In a bid to establish an ecosystem that delivers improved healthcare services across India, Prime Minister Narendra Modi announced the National Digital Health Mission (NDHM) on India's 84th Independence Day in 2020.

This existing digital infrastructure, which efficiently identifies and connects individuals and simplifies their daily lives through digital means, includes key components like the Aadhaar Unique Identity (UID), the JAM trinity (Jan Dhan-Aadhaar-Mobile), and the Unified Payments Interface (UPI). This strong digital foundation provides a solid launching pad for NDHM, facilitating further development and enhancement of healthcare services through digital management.

Market Key Developments

  • In November 2022, Medtronic launched the "Medtronic Extended Fusion Set" in the US which uses advanced materials for reducing insulin preservative loss and thereby maintaining insulin flow.

Segmentation:

By Type

  • Diagnostic and Monitoring Devices
  • Therapeutic Devices

By Application

  • Cardiovascular
  • Neurology
  • Respiratory
  • Others

By End-User

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Home Care Settings

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

  • 2.1. Research Data
  • 2.2. Assumptions

3. EXECUTIVE SUMMARY

  • 3.1. Research Highlights

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Force Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis

5. GLOBAL SMART MEDICAL DEVICES MARKET, BY TYPE

  • 5.1. Introduction
  • 5.2. Diagnostic and Monitoring Devices
  • 5.3. Therapeutic Devices

6. GLOBAL SMART MEDICAL DEVICES MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiovascular
  • 6.3. Neurology
  • 6.4. Respiratory
  • 6.5. Others

7. GLOBAL SMART MEDICAL DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals and Clinics
  • 7.3. Ambulatory Care Centers
  • 7.4. Home Care Settings

8. GLOBAL SMART MEDICAL DEVICES MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
    • 8.4.4.1. UK
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. Israel
    • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisition, Agreements and Collaboration
  • 9.4. Vendor Competitiveness Index

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. ViVO Smart Medical Devices Ltd
  • 10.3. Dexcom Inc
  • 10.4. Abbott Laboratories
  • 10.5. Medtronic Plc.
  • 10.6. NeuroMetrix, Inc.
  • 10.7. Omron Healthcare, Inc.